AP2000001787A0 - Use of thiazolidinediones for the treatment of hyperglycaemia. - Google Patents
Use of thiazolidinediones for the treatment of hyperglycaemia.Info
- Publication number
- AP2000001787A0 AP2000001787A0 APAP/P/2000/001787A AP2000001787A AP2000001787A0 AP 2000001787 A0 AP2000001787 A0 AP 2000001787A0 AP 2000001787 A AP2000001787 A AP 2000001787A AP 2000001787 A0 AP2000001787 A0 AP 2000001787A0
- Authority
- AP
- ARIPO
- Prior art keywords
- hyperglycaemia
- treatment
- thiazolidinediones
- efective
- mammal
- Prior art date
Links
- 201000001421 hyperglycemia Diseases 0.000 title abstract 2
- 229940123464 Thiazolidinedione Drugs 0.000 title 1
- 150000001467 thiazolidinediones Chemical class 0.000 title 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 231100000489 sensitizer Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9721693.1A GB9721693D0 (en) | 1997-10-13 | 1997-10-13 | Novel treatment |
PCT/GB1998/003064 WO1999018943A1 (en) | 1997-10-13 | 1998-10-12 | Use of thiazolidinediones for the treatment of hyperglycaemia |
Publications (1)
Publication Number | Publication Date |
---|---|
AP2000001787A0 true AP2000001787A0 (en) | 2000-06-30 |
Family
ID=10820482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
APAP/P/2000/001787A AP2000001787A0 (en) | 1997-10-13 | 1998-10-12 | Use of thiazolidinediones for the treatment of hyperglycaemia. |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1023056A1 (ru) |
JP (1) | JP2001519382A (ru) |
KR (1) | KR20010024481A (ru) |
CN (1) | CN1281359A (ru) |
AP (1) | AP2000001787A0 (ru) |
AU (1) | AU9547098A (ru) |
BG (1) | BG104404A (ru) |
BR (1) | BR9815219A (ru) |
CA (1) | CA2306086A1 (ru) |
CZ (1) | CZ20001297A3 (ru) |
EA (1) | EA002659B1 (ru) |
GB (1) | GB9721693D0 (ru) |
HR (1) | HRP20000255A2 (ru) |
HU (1) | HUP0003922A3 (ru) |
ID (1) | ID24521A (ru) |
IL (1) | IL135513A0 (ru) |
NO (1) | NO20001898L (ru) |
NZ (1) | NZ503862A (ru) |
OA (1) | OA11683A (ru) |
PL (1) | PL339813A1 (ru) |
SK (1) | SK5312000A3 (ru) |
TR (1) | TR200000958T2 (ru) |
WO (1) | WO1999018943A1 (ru) |
YU (1) | YU28800A (ru) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7045519B2 (en) | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2137915T3 (es) * | 1987-09-04 | 2000-01-01 | Beecham Group Plc | Derivados de tiazolidindiona sustituida. |
GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
US5478852C1 (en) * | 1993-09-15 | 2001-03-13 | Sankyo Co | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus |
-
1997
- 1997-10-13 GB GBGB9721693.1A patent/GB9721693D0/en not_active Ceased
-
1998
- 1998-10-12 CZ CZ20001297A patent/CZ20001297A3/cs unknown
- 1998-10-12 WO PCT/GB1998/003064 patent/WO1999018943A1/en not_active Application Discontinuation
- 1998-10-12 IL IL13551398A patent/IL135513A0/xx unknown
- 1998-10-12 EP EP98949086A patent/EP1023056A1/en not_active Withdrawn
- 1998-10-12 PL PL98339813A patent/PL339813A1/xx unknown
- 1998-10-12 OA OA1200000108A patent/OA11683A/en unknown
- 1998-10-12 NZ NZ503862A patent/NZ503862A/xx unknown
- 1998-10-12 TR TR2000/00958T patent/TR200000958T2/xx unknown
- 1998-10-12 AU AU95470/98A patent/AU9547098A/en not_active Abandoned
- 1998-10-12 YU YU28800A patent/YU28800A/sh unknown
- 1998-10-12 AP APAP/P/2000/001787A patent/AP2000001787A0/en unknown
- 1998-10-12 SK SK531-2000A patent/SK5312000A3/sk unknown
- 1998-10-12 KR KR1020007003934A patent/KR20010024481A/ko not_active Application Discontinuation
- 1998-10-12 ID IDW20000669A patent/ID24521A/id unknown
- 1998-10-12 EA EA200000419A patent/EA002659B1/ru not_active IP Right Cessation
- 1998-10-12 HU HU0003922A patent/HUP0003922A3/hu unknown
- 1998-10-12 JP JP2000515578A patent/JP2001519382A/ja active Pending
- 1998-10-12 CA CA002306086A patent/CA2306086A1/en not_active Abandoned
- 1998-10-12 BR BR9815219-0A patent/BR9815219A/pt not_active Application Discontinuation
- 1998-10-12 CN CN98812083A patent/CN1281359A/zh active Pending
-
2000
- 2000-04-12 NO NO20001898A patent/NO20001898L/no not_active Application Discontinuation
- 2000-05-02 HR HR20000255A patent/HRP20000255A2/hr not_active Application Discontinuation
- 2000-05-05 BG BG104404A patent/BG104404A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
NO20001898D0 (no) | 2000-04-12 |
EA002659B1 (ru) | 2002-08-29 |
PL339813A1 (en) | 2001-01-02 |
IL135513A0 (en) | 2001-05-20 |
ID24521A (id) | 2000-07-20 |
SK5312000A3 (en) | 2000-09-12 |
NZ503862A (en) | 2003-01-31 |
KR20010024481A (ko) | 2001-03-26 |
CZ20001297A3 (cs) | 2001-08-15 |
BG104404A (bg) | 2000-12-29 |
BR9815219A (pt) | 2001-01-02 |
HRP20000255A2 (en) | 2001-02-28 |
CA2306086A1 (en) | 1999-04-22 |
HUP0003922A2 (hu) | 2001-10-28 |
EP1023056A1 (en) | 2000-08-02 |
YU28800A (sh) | 2003-02-28 |
AU9547098A (en) | 1999-05-03 |
EA200000419A1 (ru) | 2000-10-30 |
TR200000958T2 (tr) | 2000-08-21 |
WO1999018943A1 (en) | 1999-04-22 |
JP2001519382A (ja) | 2001-10-23 |
HUP0003922A3 (en) | 2001-12-28 |
CN1281359A (zh) | 2001-01-24 |
GB9721693D0 (en) | 1997-12-10 |
OA11683A (en) | 2005-01-12 |
NO20001898L (no) | 2000-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1787646A3 (en) | Novel method of treatment | |
MXPA05007470A (es) | Metodo para reducir la morbilidad y mortalidad cardiovascular en pacientes prediabeticos y pacientes con diabetes de tipo 2. | |
WO2000007575A3 (en) | Methods and compositions for increasing insulin sensitivity | |
SG127714A1 (en) | Method of treating metabolic disorders, especiallydiabetes, or a disease or condition associated wi th diabetes | |
MXPA03003870A (es) | Terapia de combinacion que comprende agentes antidiabeticos y anticonvulsionantes. | |
CA2071629A1 (en) | Use of insulin sensitizing agents to treat hypertension | |
AP2001002291A0 (en) | Novel method of treatment. | |
WO2003082260A3 (en) | Tuberculosis treatment using pleuromutilin derivatives | |
MY155219A (en) | Treatment of diabetes with thiazolidinedione, insulin secretagogue and biguanide | |
HK1047707A1 (zh) | (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途 | |
AU5547501A (en) | Method of reducing side effects of chemotherapy in cancer patients | |
NO994165L (no) | Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet | |
AU1720697A (en) | Nutrient composition for exercise | |
AP9901720A0 (en) | Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitors. | |
MY125855A (en) | Treatment of diabetes with a thiazolidinedione and sulphonylurea | |
MY138246A (en) | Treatment of diabetes with thiazolidione and sulphonylurea. | |
AP2000001735A0 (en) | Treatment of diabetes with thiazolidinedione insulin secretagogue and alpha glucocidase inhibitor. | |
AP2000001787A0 (en) | Use of thiazolidinediones for the treatment of hyperglycaemia. | |
CA2234936A1 (en) | Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine | |
TR200101336T2 (tr) | Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar | |
WO1999064065A3 (en) | Tumour therapy and imaging | |
YU28700A (sh) | Upotreba potencijatora osetljivosti na insulin u proizvodnji leka za lečenje hiperglikemije | |
MX9701606A (es) | Terapia de combinacion para evitar la perdida osea-progesterona y agonistas de estrogeno. | |
AU4937499A (en) | Use of succinic acid or salts thereof and method of treating insulin resistance | |
EP0904094A4 (en) | TREATMENT OF BONE DISEASES WITH ADRENOMEDULLIN |